Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
- Study Title
- A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
- Teva Identifier
- TV1106-IMM-20001 | 2013-004468-69
- ClinicalTrials.gov Identifier
- NCT02092077
- Study Status
- Terminated
- Trial Condition(s)
- Growth Hormone-Deficiency
- Interventions
- Drug: TV-1106 | Drug: somatropin
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child
- Age Range
- 3 Years to 11 Years
- Trial Duration
- April 30, 2014 - August 31, 2016
- Phase
- Phase 2
